The effect of prenatal ASA ingestion on hemostasis was investigated in 59 maternal-neonate pairs. Group I consisted of 36 control pairs in whom a negative ASA drug history was substantia ted by normal maternal and neonatal platelet aggregations and values for the prostaglandin byproduct malonyldialdehyde (MDA). Group I1 consisted of 16 pairs in whom a positive history for maternal ASA ingestion was confirmed by the expected abnormalities in platelet aggregations and MDA. Group 111 comprised 7 maternal-neonate pairs where maternal ASA ingestion occurred within 6 hours post partum. All groups were evaluated for hemostatic abnormalities. Maternal blood loss was considered excessive, if a drop of >lo% between initial and discharge hemoglobin occurred (vaginal delivery), or >25% (C section). In Group I, no maternal hemostatic abnormalities were noted, although 1/34 neonates demonstrated facial ecchymoses. In 10/16 Group I1 pairs where maternal ASA ingestion had occurred 0-5 days prior to delivery, clinical evidence of bleeding occurred in 90% (9110) of the infants, and 60% (6/10) of the mothers. In contrast, in 6/16 Group I1 pairs, where ASA ingestion had occurred 6-10 days prior to delivery, no abnormalities were found. Group I11 infants were normal, although 57% (417) mothers in this group bled abnormally. ASA ingested in the 5 days prior to delivery, r immediately ost artum is associated with hemostatic abnorLlities In botR motRer anA neonate.
RECURRENCE OF PNEUMOCYSTIS CARINII PNEUMONIA IN PATIENTS liITH ACUTE LYMPHOBLASTIC LEUKEEIIA. Kamran
Tebbi and Samuel Gross, Dept. of Peds., CWRU, Cleveland, Ohio.
Patients receiving immunosuppressive therapy are at increased risk for pneumocystis carinii pneumonitis (PCP). However, recurrence of PCP is seldom documented. This report concerns recurrence of PCP in 2 patients with acute lymphoblastic leukemia (ALL) in continuous remission on maintenance therapy. An 8-year old girl, now 5 years post diagnosis, developed pneumoni: on 6 occasions beginning 16 months post diagnosis. Lung biopsie! x2 were diagnostic of PCP. A 14-year old girl developed 2 episodes of PCP, proven by open lung biopsy, at 19 and 36 month! following diagnosis. One year later, she relapsed and died. Post mortem examination failed to show evidence of PCP. In botl cases, PCP recurred despite adequate therapy of each episode an( complete radiological clearing of the lungs. In the 8-year old, pulmonary function tests showed a decrease in all volume components, suggestive of a restrictive pattern without obstruction, presumably a sequelae of recurrent pneumonitis. On daily prophj laxis she remains disease-free. With combination chemotherapy and irradiation, many patients survive for extended periods of time. In children with ALL in continuous remission, PCP is a major cause of death due to infection(l6-35x in various studies) Recurrent pneumonitis in immunosuppressed patients should raise a high index of suspicion of PCP, which, if identified following lung biopsy, should be treated and followed with continuou~ prophylaxis.
, Case Western ics. Cleveland, 0 not clear. Deof parasitic and ated. This suggests a possible inhibitory effect of eosinophile n granulopoiesis. This study was undertaken to examine the ffects of eosinophiles on granulocytic colony forming units in ulture (CFU-C) of mice bone marrow (BM).
Marrow of normal as ell as eosinophilic inbread C-57 black mice infected with Trihinella spiralis was cultured in semi-solid media with 1) antieosinophilic sera produced against mice eosinophiles in rabbit AES), 2) the addition of purified eosinophiles, 3) colony stimuating activity (CSA), 4) a-culture media, 5) normal rabbit serum ) eosinophilia extracts, and 7) irradiated eosinophiles. Each o he above experiments was repeated with and without added CSA. ddition of AES to BM cultures containing CSA sharply increased FU-C levels in eosinophilic mice compared to CSA and rabbit ser controls) alone (P<0.01), but had no effect on normal BM. Addi ion of increased numbers of eosinophiles significantly decrease he number of CFU-C in normal and eosinophilic mice (P<0.01). SA was necessary to promote colony production and to enhance the ffects of AES in eosinophilic mice. , heterophil negative lympho-proliferative disease are described. The sister presented first with heterophil negative infectious mononucleosis which was virologically confirmed EBV and which progressed to a fatal outcome. Cervical node biopsy revealed lymphocytes containing both EBV nuclear antigen (EBV-EBNA) and EBV early antigen (EBV-EA). At autopsy, there was widespread infiltration of spleen, lymph nodes, lungs and heart with lymphocytes demonstrating both of these EBV-coded antigens. Subsequently, her brother presented with a picture of disseminated lympho-proliferative disease which was serologically and virologically confirmed as due to EBV. T6A and cervical node biopsy were shown to harbor numerous EBV-EBNA and EBV-EA lymphocytes. A short period of improvement occurred to be followed by recurrence leading ultimately to re-evaluation. Cervical node biopsy followed by staging laparotomy demonstrated Stage 111-B mixed cellular Hodgkin's Disease. In these speciments, there was again confirmation of the presence of EBV. X-ray therapy and multiple agent chemotherapy has been followed by remission of the Hodgkin's Disease. Concurrent studies of EBV serology reflects this fact also.
Details of the pathologic studies and EBV virus studies will be presented. It is postulated that in this child EBV virus can be implicated etiologically in his Hodgkin's Disease in a prospective study. Leukocytosis with predominance of polymorphonuclear leukocyte occurs in a variety of primary or metastatic hepatic tumors with nut apparent explanation. A 17-year-old male with lymphoepithelioma developed marked leukocytosis following the onset of liver metastases. In order to gain insight into the origin of the leu kocytosis, granulopoietic colony stimulating activity (CSA) of patient's plasma and leukocytes were examined and compared to control. Leukocyte conditioned media (LCM) was prepared by the double layer culture method. The assay consisted of non-adhere1 marrow cells from normal individuals cultured in methylcellulosi fetal calf serum and a-media. With the various CSA sources in this system, the number of granulocytic colony forming units (CFU-C) is proportional to the amount of CSA present and therefore allows for quantitative comparisons. The number of CFU-C produced with the patient's plasma was significantly higher (P<0.001) than those obtained from the patient's LCM or from cor trol plasma or LO!.
The size and distribution of colony type wt similar irrespective of the source of CSA. Major sources of CSI in man are macrophages and monocytes. Thus identification of a stronger stimulatory activity in plasma as compared to LCFf indicates the presence of a major new source of CSA in this patient. The fact that leukocytosis paralleled the anset of liver metastases suggests that a CSA derived from tumor products or secondary to hepatocellular damage may be responsible for this findinj SUCCESSFUL BONE MARROW TRANSPLANTATION (BMT) FOR 672 PLASTIC ANEMIA WITH AN HLA-mc NoN-IDENTIcAL PARENT ONOR. Phyllis Warkentin, Mark Nesbit, Peter Coccia, Krivit, Norma Ramsay, and John Kersey. Dept. of Pediatrics, Minneapolis. 55455. Successful BMT was performed in a 9 yr. old black.female with severe idiopathic aplastic anemia from her HLA-MLC non-identical father. Initial Hgb.=3.8 gm.%, retic. count=0.1%, WBC-700 cmm., platelets=10,000 cmm.; bone marrow biopsy was markedly hypocellu. lar with 85% non-hematopoietic elements. Tissue typing showed th, patient to be HLA A-1 B-8. A-26 8-7; the father was HLA A-1 B-8, A-3 B-7. In mixed leukocyte culture (MLC), there was low but sig nificant bidirectional (10%; 16%) stimulation. Cell mediated lympholysis demonstrated no significant killing. Pre-transplant preparation included Procarbazine 15 mglkglday x 3 days, antithymocyte globulin (ATG) 15 mglkglday x 3 days, and 750 rads of total body irradiation by linear accelerator. Cells from the donor (6.9 x 108/kg) were infused intravenously. Craft versus host (GVH) prophylaxis following BMT consisted of IV Methotrexat ~eekly x 100 days and ATG and corticosteroids on days 7-21. By lay 28 post BMT, cells of donor HLA type were present and marrow :hromosomes were 100% XI. On days 29-31 mild GVH developed with fever, rash and slight liver enzyme elevations. Skin biopsy was :onsistent with GVH. Skin GVH resolved with Prednisone treatment At 7 months post BMT peripheral counts are normal, however liver enzyme elevations persist. Marrow engraftment with minimal GVH in this patient should encourage further trials of BMT in patients without HLA-MLC identical siblinns.
